E-ISSN: 2619-9467

Contents    Cover    Publication Date: 28 Jun 2024
Year 2024 - Volume 34 - Issue 2

Open Access

Peer Reviewed

ORIGINAL RESEARCH
116 Viewed151 Downloaded

Disseminated Intravascular Coagulation in Abruptio Placenta: Who is at Risk?

Full Text PDF  
JCOG. 2024;34(2):60-6
DOI: 10.5336/jcog.2023-101168
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: This study aimed to determine the clinical risk factors of disseminated intravascular coagulation (DIC) in case of an abruptio placenta. The second objective was to evaluate the maternal and perinatal complications in the cases with DIC secondary to abruptio placenta. Material and Methods: This is a retrospective study conducted in pregnant women with a diagnosis of abruption at a tertiary maternity hospital. 237 patients confirmed with abruptio placenta were assigned into two groups: complicated with DIC (study group), and those who were not (control group). Results: 23 patients were included in the study group, and 214 patients were included in the control group. In the study group, 82.6% of the patients were admitted urgently from the emergency room with diagnosis of abruption, whereas the rate of the patients diagnosed in the emergency room was 49.1% in the control group (p=0.002). The rate of cases with a ≥50% detachment of the total placental mass was significantly higher in the DIC group (91.3% vs. 41.7%). Uterine atony, Couvelaire uterus, transfusion of blood products, intensive care unit admission were significantly higher in the DIC group. Intrauterine fetal demise, neonatal excess base deficit, neonatal intensive care unit admission were also significantly higher in the DIC group. Conclusion: The patients presenting with vaginal bleeding, fetal demise, those who have ≥50% of the placenta detached, and those who are diagnosed in emergency department have higher likelihood of being complicated with DIC. The patients with known risk factors for abruption and their neonates benefit from in-patient follow-up.
REFERENCES:
  1. Ananth CV, Lavery JA, Vintzileos AM, Skupski DW, Varner M, Saade G, et al. Severe placental abruption: clinical definition and associations with maternal complications. Am J Obstet Gynecol. 2016;214(2):272.e1-272.e9. [Crossref]  [PubMed] 
  2. Downes KL, Grantz KL, Shenassa ED. Maternal, labor, delivery, and perinatal outcomes associated with placental abruption: a systematic review. Am J Perinatol. 2017;34(10):935-57. [Crossref]  [PubMed]  [PMC] 
  3. Pitaphrom A, Sukcharoen N. Pregnancy outcomes in placental abruption. J Med Assoc Thai. 2006;89(10):1572-8. [PubMed] 
  4. Toh CH, Hoots WK; SSC on Disseminated Intravascular Coagulation of the ISTH. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007;5(3):604-6. [Crossref]  [PubMed] 
  5. Brandt JS, Ananth CV. Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management. Am J Obstet Gynecol. 2023;228(5S):S1313-S29. [Crossref]  [PubMed]  [PMC] 
  6. Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011;90(2):140-9. [Crossref]  [PubMed] 
  7. Gonen N, Levy M, Kovo M, Schreiber L, Noy LK, Volpert E, et al. Placental histopathology and pregnancy outcomes in "early" vs. "late" placental abruption. Reprod Sci. 2021;28(2):351-60. [Crossref]  [PubMed] 
  8. Ananth CV, Oyelese Y, Prasad V, Getahun D, Smulian JC. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):15-21. [Crossref]  [PubMed] 
  9. Downes KL, Grantz KL, Shenassa ED. Maternal, labor, delivery, and perinatal outcomes associated with placental abruption: a systematic review. Am J Perinatol. 2017;34(10):935-57. [Crossref]  [PubMed]  [PMC] 
  10. Schur E, Baumfeld Y, Rotem R, Weintraub AY, Pariente G. Placental abruption: assessing trends in risk factors over time. Arch Gynecol Obstet. 2022;306(5):1547-54. [Crossref]  [PubMed] 
  11. Kundu G, Begum SA, Afroz H, Mamud T, Sultana Z, Faruq M. Relaparotomy following caesarean section: a cross sectional study. Mymensingh Med J. 2021;30(4):1023-30. [PubMed] 
  12. Jones RM, de Lloyd L, Kealaher EJ, Lilley GJ, Precious E, Burckett St Laurent D, et al; collaborators. Platelet count and transfusion requirements during moderate or severe postpartum haemorrhage. Anaesthesia. 2016;71(6):648-56. [Crossref]  [PubMed] 
  13. McNamara H, Kenyon C, Smith R, Mallaiah S, Barclay P. Four years' experience of a ROTEM® -guided algorithm for treatment of coagulopathy in obstetric haemorrhage. Anaesthesia. 2019;74(8):984-91. [Crossref]  [PubMed] 
  14. Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 2009;23(4):167-76. [Crossref]  [PubMed] 
  15. Shoopala HM, Hall DR. Re-evaluation of abruptio placentae and other maternal complications during expectant management of early onset pre-eclampsia. Pregnancy Hypertens. 2019;16:38-41. [Crossref]  [PubMed]